Safety Strategy & Optimization
Maximize the Value of Your Safety Operations
It’s time to transform pharmacovigilance from a cost center to a value center.
Safety organizations face many challenges: increasing volume and complexity of adverse event cases, scrutiny from regulatory authorities and internal inefficiencies like overworked staff, insufficient metrics and outdated processes.
Implement a New Strategy for Safety
As part of the Lifecycle Safety suite of solutions, Quintiles offers Safety Strategy & Optimization consulting services to help you develop strategies to increase efficiency and compliance, and improve the quality and value of your medical and scientific data.
Our consultants leverage knowledge culled from decades of on-the-ground experience in clinical and commercial services. Combined with our proprietary capabilities assessment framework, we can help you:
- Effectively respond to variable caseload volume
- Implement best-in-class medical information analysis methodologies
- Establish and operate on reliable and meaningful metrics
- Build deep signal detection skills
Developing these capabilities leads to better benefit / risk assessment and helps you transform from a reactive to an anticipating organization.
Optimize the Value of Your Data
We will help you become more effective at spotting trends in adverse event data and better leverage the data to improve clinical and commercial outcomes. Using your data in this manner can reduce the cost of responding to safety events, improve patient safety and enhance the overall value of pharmacovigilance to your organization.
Partner with an Ally who Understands Your Business
Our staff comes from industry, regulatory agencies and top consulting companies, and is backed by the expertise of hundreds of Quintiles medical and safety experts who processed more than 140,000 safety reports and 7,800 endpoint cases and produced 65,000 regulatory submissions and 356 Annual Safety Reports in 2009 alone.
We understand the strategic, operational, technical, scientific and medical issues today’s pharmacovigilance organizations face. We’ll consider each of these perspectives as we tailor a plan to meet your needs. For more information please explore the links on the sidebar or contact us today.
